Get startedLog in
    Picture of RaQualia Pharma logo

    4579 — RaQualia Pharma Cashflow Statement

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for RaQualia Pharma, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:YuhoYuhoYuhoYuhoYuho
    Standards:
    JAS    		—
    JAS
    JAS
    JAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-528881851-294-358
    Depreciation
    Amortisation
    Non-Cash Items34.4-138109-32.7186
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital80-518373-567-48.9
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Taxes Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-2893661,480-719181
    Capital Expenditures-156-105-31.9-222-116
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items382-174-15.786.8-3,550
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities225-279-47.6-135-3,666
    Financing Cash Flow Items—0.0010.001-0.001-0.001
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-6.96-16.4-29.67932,982
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-1391791,439-14.6-523